NO20020751L - Kjemisk stabiliserte klorittlösninger for behandling av cancer og andre sykdommer - Google Patents
Kjemisk stabiliserte klorittlösninger for behandling av cancer og andre sykdommerInfo
- Publication number
- NO20020751L NO20020751L NO20020751A NO20020751A NO20020751L NO 20020751 L NO20020751 L NO 20020751L NO 20020751 A NO20020751 A NO 20020751A NO 20020751 A NO20020751 A NO 20020751A NO 20020751 L NO20020751 L NO 20020751L
- Authority
- NO
- Norway
- Prior art keywords
- stabilized chlorite
- cancer
- treatment
- chlorite matrix
- diseases
- Prior art date
Links
- 229910001919 chlorite Inorganic materials 0.000 title abstract 5
- 229910052619 chlorite group Inorganic materials 0.000 title abstract 5
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000011159 matrix material Substances 0.000 abstract 4
- 210000002540 macrophage Anatomy 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000008070 Interferon-gamma Human genes 0.000 abstract 1
- 108010074328 Interferon-gamma Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010054094 Tumour necrosis Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 231100000504 carcinogenesis Toxicity 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 210000002865 immune cell Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 229960003130 interferon gamma Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000010309 neoplastic transformation Effects 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14942999P | 1999-08-18 | 1999-08-18 | |
| PCT/US2000/022610 WO2001012205A2 (en) | 1999-08-18 | 2000-08-18 | Chemically-stabilized chlorite solutions for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20020751D0 NO20020751D0 (no) | 2002-02-15 |
| NO20020751L true NO20020751L (no) | 2002-04-17 |
Family
ID=22530238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20020751A NO20020751L (no) | 1999-08-18 | 2002-02-15 | Kjemisk stabiliserte klorittlösninger for behandling av cancer og andre sykdommer |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1408994A2 (de) |
| KR (1) | KR20020038728A (de) |
| CN (1) | CN1378456A (de) |
| AU (1) | AU6913200A (de) |
| CA (1) | CA2382293A1 (de) |
| IL (1) | IL148189A0 (de) |
| MX (1) | MXPA02001724A (de) |
| NO (1) | NO20020751L (de) |
| NZ (1) | NZ517673A (de) |
| PL (1) | PL353769A1 (de) |
| RU (1) | RU2002106824A (de) |
| TR (1) | TR200201182T2 (de) |
| WO (1) | WO2001012205A2 (de) |
| ZA (1) | ZA200201726B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2337258T3 (es) | 2003-11-21 | 2010-04-22 | Cytotools Ag | Compuestos de cloro reactivos, los derivados, aniones y sales de los mismos, metodos para su produccion y su uso. |
| ATE546148T1 (de) * | 2005-07-21 | 2012-03-15 | Nuvo Res Ag | Stabilisierte chlorit-lösungen in kombination mit fluorpyrimidinen zur krebsbehandlung |
| IN2014DN05866A (de) | 2011-12-22 | 2015-05-22 | Nuvo Res Gmbh | |
| CN112386606A (zh) * | 2019-08-19 | 2021-02-23 | 卢序 | 一种有第二信使作用增加积极氧化压力的氧化剂的用途 |
| CN115666593B (zh) * | 2020-05-21 | 2025-11-25 | 国立大学法人大阪大学 | 上皮癌治疗药 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3515749A1 (de) * | 1985-05-02 | 1986-11-06 | Oxo Chemie GmbH, 6900 Heidelberg | Verwendung einer stabilisierten chloritmatrixloesung bei infektioesen zustaenden |
| DE3515748A1 (de) * | 1985-05-02 | 1986-11-06 | Oxo Chemie GmbH, 6900 Heidelberg | Verwendung einer isotonen chloritmatrix-loesung bei der behandlung von tumoren |
| AU754928B2 (en) * | 1997-10-06 | 2002-11-28 | Oxo Chemie Ag | Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| ATE309960T1 (de) * | 1999-02-19 | 2005-12-15 | Kurt-Wilhelm Prof Dr Dr Stahl | Peroxochlorsaure, derivate und anionen, salze davon, und verfahren zu deren herstellung und verwendung |
-
2000
- 2000-08-18 CN CN00814063A patent/CN1378456A/zh active Pending
- 2000-08-18 PL PL00353769A patent/PL353769A1/xx unknown
- 2000-08-18 CA CA002382293A patent/CA2382293A1/en not_active Abandoned
- 2000-08-18 IL IL14818900A patent/IL148189A0/xx unknown
- 2000-08-18 TR TR2002/01182T patent/TR200201182T2/xx unknown
- 2000-08-18 EP EP00957529A patent/EP1408994A2/de not_active Withdrawn
- 2000-08-18 WO PCT/US2000/022610 patent/WO2001012205A2/en not_active Ceased
- 2000-08-18 AU AU69132/00A patent/AU6913200A/en not_active Abandoned
- 2000-08-18 NZ NZ517673A patent/NZ517673A/en not_active IP Right Cessation
- 2000-08-18 MX MXPA02001724A patent/MXPA02001724A/es unknown
- 2000-08-18 RU RU2002106824/14A patent/RU2002106824A/ru not_active Application Discontinuation
- 2000-08-18 KR KR1020027002066A patent/KR20020038728A/ko not_active Withdrawn
-
2002
- 2002-02-15 NO NO20020751A patent/NO20020751L/no not_active Application Discontinuation
- 2002-03-01 ZA ZA200201726A patent/ZA200201726B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6913200A (en) | 2001-03-13 |
| WO2001012205A3 (en) | 2001-09-13 |
| WO2001012205A2 (en) | 2001-02-22 |
| NO20020751D0 (no) | 2002-02-15 |
| KR20020038728A (ko) | 2002-05-23 |
| NZ517673A (en) | 2004-03-26 |
| RU2002106824A (ru) | 2003-11-27 |
| PL353769A1 (en) | 2003-12-01 |
| CA2382293A1 (en) | 2001-02-22 |
| EP1408994A2 (de) | 2004-04-21 |
| IL148189A0 (en) | 2002-09-12 |
| MXPA02001724A (es) | 2004-09-06 |
| CN1378456A (zh) | 2002-11-06 |
| ZA200201726B (en) | 2003-12-31 |
| TR200201182T2 (tr) | 2002-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fischer et al. | Treatment of psoriasis with trioxsalen baths and dysprosium lamps | |
| NO981392D0 (no) | Substituerte pyrazolylbenzensulfonamider for anvendelse i veterinærterapi som antiinflammatorisk middel | |
| NO20002409L (no) | FremgangsmÕte for Õ produsere arsen trioksyd formuleringer og metoder for Õ behandle cancer ved Õ bruke arsen trioksyd eller melarsoprol | |
| PT724457E (pt) | Sensibilizacao a radiacao utilizando texafirinas | |
| DE69923671D1 (de) | Verwendung von kannabidiol als entzündunghemmende mittel | |
| DK499086A (da) | Konjugater af trichothecen og anvendelse af samme som terapeutisk substans | |
| NO932610L (no) | Fremgangsmaate for behandling av tumornekrosefaktor formidlede sykdommer | |
| ES2148217T3 (es) | Procedimiento de tratamiento de infecciones bacterianas no estreptococicas. | |
| NO934706L (no) | Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner | |
| NO980420L (no) | Anvendelse av griseofulvin for å inhibere cancervekst | |
| NO975662L (no) | Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer | |
| NO20020751L (no) | Kjemisk stabiliserte klorittlösninger for behandling av cancer og andre sykdommer | |
| CA2339384A1 (en) | Improved method for targeted topical treatment of disease | |
| WO1990006748A3 (en) | Use of certain herbicides in cancer treatment and production of protoporphyrin ix | |
| BRPI0412424A (pt) | composto, composição farmacêutica, método para tratar doenças dermatológicas ou cancerosas em um mamìfero, composição, e, método para tratar doenças relacionadas com a pele ou cancerosas | |
| DK522186D0 (da) | Melatoninmaterialer og deres anvendelser | |
| ATE69953T1 (de) | Verwendung von polysulfatierten heparinen. | |
| EP1100507A4 (de) | Antioxidative zusammenstellung und deren verwendung zur behandlung von erkrankungen | |
| NO890046D0 (no) | Disubstituerte pyridiner. | |
| MY108848A (en) | Compositions and method of treating depigmentation disorders. | |
| TR199903074T2 (xx) | Kanser tedavisinde HMG CoA ve farnesil transfer �nleyicileri. | |
| IL312037A (en) | Endoxifen for treatment of cancers | |
| DK0486395T3 (da) | Vandig gel på basis af retinoesyre og hydroxypropyl-beta-cyclodextrin | |
| MX9206135A (es) | Metodos | |
| WO2003049683A3 (en) | Use of parapox b2l protein to treat cancer and modify immune responses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |